Evidence map›Paper›PMID 38749721›Full record

ArticleJournal of clinical and experimental hematopathology : JCEH2024

Patient perspectives on treatment for mantle cell lymphoma and chronic lymphocytic leukemia in Japan.

Toru Kiguchi, Yasushi Hiramatsu, Shuichi Ota, Michihiro Uchiyama, Moe Matsuo, Miyu Okamura, Shimpei Morimoto, Yoshinori Tanizawa, Masaomi Tajimi, Nalin Payakachat

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of clinical and experimental hematopathology : JCEH, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Toru KiguchiDivision of Diabetes, Endocrinology and Hematology, Dokkyo Medical University Saitama Medical Center, Koshigaya, Japan.
Yasushi HiramatsuDepartment of Hematology and Oncology, Japanese Red Cross Society Himeji Hospital, Himeji, Japan.
Shuichi OtaDepartment of Hematology, Sapporo Hokuyu Hospital, Sapporo, Japan.
Michihiro UchiyamaDepartment of Hematology, Japanese Red Cross Society Suwa Hospital, Suwa, Japan.
Moe MatsuoSyneos Health Clinical K.K., Tokyo, Japan.
Miyu OkamuraSyneos Health Clinical K.K., Tokyo, Japan.
Shimpei MorimotoSyneos Health Clinical K.K., Tokyo, Japan.
Yoshinori TanizawaEli Lilly Japan K.K., Kobe, Japan.
Masaomi TajimiEli Lilly Japan K.K., Kobe, Japan.
Nalin PayakachatEli Lilly and Company, Indianapolis, IN, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The increasing number of treatment options for patients with mantle cell lymphoma (MCL) and chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL) in Japan underscores the critical need to comprehend their treatment preferences. In this study, individual semi-structured interviews with 20 Japanese patients with diagnosis of MCL or CLL/SLL were conducted and qualitatively analyzed to elicit concepts important for patients regarding treatment selection. Although effectiveness and safety were imperative for treatment selection, convenience and quality of life were also reported as important attributes. Over the course of their disease journey, patients reported diverse and changing preferences in terms of treatment characteristics. Additionally, there was a discrepancy between their desired and actual levels of involvement in shared decision-making with physicians about treatment choices. Optimal personalized care for better outcomes of patients with MCL and CLL/SLL hinges on healthcare professionals acknowledging individual patient needs and preferences within their cultural, societal and personal context.

Indexed as

Leukemia, Lymphocytic, Chronic, B-CellLymphoma, Mantle-CellAdultAgedAged, 80 and overFemaleHumansJapanMaleMiddle AgedQuality of Lifechronic lymphocytic leukemiamantle-cell lymphomapatient involvementpatient perspectivesqualitative interview

Identifiers

PMID38749721
PMCPMC11303965

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.